Bile Acid Synthesis Disorders clinical trials at University of California Health

• The REPLACE Registry for Cholbam® (Cholic Acid)

  open to all eligible people

  This is a prospective, observational, non-interventional patient registry study designed to document product safety and effectiveness outcomes for 10 years in patients treated with Cholbam, including those who have been using Cholbam for at least 30 days (existing users) and those who are first-time initiators of Cholbam.

  at UCSF

Last updated: September 30, 2021